Chenglong Chen

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsCompound semiconductorsHaematological tumoursBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 30, 2025
Exploiting B7-H3: Molecular Insights and Immunotherapeutic Strategies for Osteosarcoma.

Yuhang Xie, Hongru Wang, Fanwei Zeng

|Nov 21, 2023
Dural Reconstruction Materials for the Repairing of Spinal Neoplastic Cerebrospinal Fluid Leaks.

Shidong Wang, Shangjun Ren, Juan Wang

|Feb 27, 2023
Nanosized drug delivery strategies in osteosarcoma chemotherapy.

Chenglong Chen, Shidong Wang, Juan Wang

|Dec 12, 2022
Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma.

Chenglong Chen, Qianyu Shi, Jiuhui Xu

|Jul 01, 2020
Niclosamide and its derivative DK-520 inhibit RANKL-induced osteoclastogenesis.

Yurui Jiao, Chenglong Chen, Xijian Hu

Pageof 2